About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in Phoenix | 41 Studies

Clinical Trials LupusPhoenix

Lupus Clinical Trials in Phoenix

Find 41 clinical trials for lupus near Phoenix, Arizona. Connect with research centers in your area.

All Lupus trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 41 trials

Active not recruitingA Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE)…NCT05617677·Birmingham, Alabama and 196 others

Lupus Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of LY2127399 in Participants With Systemic Lupus ErythematosusThe purpose of this SLE study is to evaluate the efficacy, safety and tolerability of two different doses of LY2127399 administered in participants with active SLE.NCT01196091·Birmingham, Alabama and 191 others

RecruitingStudy of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VThe overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.NCT05268289·Phoenix, Arizona and 102 others

CompletedA Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an AutoinjectorThe primary objective of this study is to assess the suitability of the autoinjector for self-administration of belimumab by subjects with SLE in real-life conditions.NCT02124798·Birmingham, Alabama and 26 others

CompletedSafety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without GlomerulonephritisThis is a 2-part, multi-center, randomized, double-blind, placebo-controlled, multiple dose escalation study, enrolling approximately 48 subjects.NCT00818948·Phoenix, Arizona and 11 others

CompletedBelimumab Assessment of Safety in SLEThe purpose of this study is to further enhance the existing knowledge regarding the side effects of belimumab when given with other lupus medicines to adults with active systemic…NCT01705977·Anniston, Alabama and 249 others

CompletedA Study of AMG 557 in Adults With Systemic Lupus ErythematosusThis is a Phase 1, randomized, placebo-controlled, double-blind, dose-escalation study of repeat SC doses of AMG 557 in adults with Systemic Lupus Erythematosus.NCT00774943·Anniston, Alabama and 11 others

TerminatedA Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)The purpose of this study was to assess the efficacy and safety of zetomipzomib (30 mg or 60 mg) compared with placebo in achieving renal response after 52 weeks of treatment in…NCT05781750·Lake Charles, Louisiana and 49 others

CompletedStudy to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)The primary purpose of the study is to evaluate the efficacy of BIIB059 (litifilimab) in reducing disease activity in participants with systemic lupus erythematosus (SLE) with…NCT02847598·Anniston, Alabama and 127 others

Active not recruitingSubcutaneous Anifrolumab in Adult Patients With Systemic Lupus ErythematosusThe purpose of this study is evaluating the efficacy and safety of SC antifrolumab in adult patients with moderate -to-severe SLE despite receiving standard therapyNCT04877691·Birmingham, Alabama and 139 others

CompletedA Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusPrimary objective: To assess the efficacy and safety of different dose regimens of ALX-0061 administered subcutaneously (s.c.) to subjects with moderate to severe active…NCT02437890·Birmingham, Alabama and 117 others

CompletedA Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long…NCT04294667·Birmingham, Alabama and 176 others

Active not recruitingProgram to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems.NCT05843643·Chandler, Arizona and 368 others

Active not recruitingA Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)The purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) including lupus nephritis…NCT07015983·Phoenix, Arizona and 96 others

CompletedA Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus ErythematosusThis is a multicenter, randomized, double-blind, placebo-controlled, sequential rising single-dose study in which approximately 56 subjects with SLE will be enrolled in 7 dosing…NCT02391259·Anniston, Alabama and 12 others

TerminatedA Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.The purpose of this study is to learn about the effects, safety and how PF-06823859 is processed in adults with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus…NCT05879718·Birmingham, Alabama and 18 others

CompletedStudy of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosusthis study extension objective is to evaluate the safety and tolerability of a 200-mcg dose every 4 weeks for 24 weeks of IPP-201101 in patients with active systemic lupus…NCT03427151·Los Angeles, California and 13 others

CompletedALPN-101 (Acazicolcept) in Systemic Lupus ErythematosusThis is Phase 2, multinational, randomized, blinded study to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacokinetics and pharmacodynamics of ALPN-101…NCT04835441·Anniston, Alabama and 45 others

Enrolling by invitationA Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus ErythematosusThe purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.NCT04976322·Birmingham, Alabama and 118 others

TerminatedA Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have…NCT03843125·Birmingham, Alabama and 296 others

Page 1 of 3Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia